coultreon biopharma is a startup based in Belgium, most recent round Series A, 1 tracked investor.
coultreon biopharma is a company headquartered in Belgium. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
Coultreon Biopharma develops life-changing medicines for patients affected by chronic inflammatory diseases of high unmet medical needs, focusing on creating oral drugs that modulate the immune system and reduce pro-inflammatory cytokine production, particularly through targeting the SIK3 pathway.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.